Company / Capital Returned to Shareholders per Share
CUMBERLAND PHARMACEUTICALS INC Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.02
FY2025
5-year range
$0.02 / $0.23
FY2021-FY2025
Trend
-64.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Returned to Shareholders per Share has declined for 4 consecutive years, from $0.23 in FY2021 to $0.02 in FY2025.
Based on SEC 10-K filings.
0.02 in FY2025 with a 5-year CAGR of -31.1%.
Declined from $0.07 to $0.02 over the past 2 years.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -41.4%
- 5-Year CAGR
- -31.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- CUMBERLAND PHARMACEUTICALS INC's capital returned to shareholders per share has declined for 4 consecutive years.
- In FY2025, capital returned to shareholders per share decreased 64.0% year-over-year.
- Peak capital returned to shareholders per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | -64.0% |
| FY2024 | $0.05 | -28.5% |
| FY2023 | $0.07 | -22.1% |
| FY2022 | $0.09 | -59.7% |
| FY2021 | $0.23 | +92.2% |
| FY2020 | $0.12 | -46.3% |
| FY2019 | $0.23 | +44.0% |
| FY2018 | $0.16 | -52.8% |
| FY2017 | $0.33 | +26.1% |
| FY2016 | $0.26 | -6.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026